- “IP is a driver for companies to be innovative, invent something new. It is important that governments create the right policy framework and necessary incentives to upscale innovation.” – Bertrand Piccard, founder of Solar Impulse Foundation, in the International Chamber of Commerce Newsroom
- “Innovation policy and IP policy play a silent role in supporting new ideas and investment… Businesses place expensive bets on the future, which is fraught with risk. The pandemic has increased risk. Rapid response requires confidence in an IP system that works and policy that supports business.” – Danny Marti, Head of Global Public Policy & Government Affairs at RELX and Vice Chairman of the Global Innovation Policy Center, in IP Watchdog
- “Even in a period of such challenge and adversity, businesses and governments alike can be on the look-out for how digitization, technology and IP can provide opportunities for innovation, and the regulatory framework can evolve and be responsive to facilitate the adoption of new technology models.” – Lam Chung Nian, Head of Intellectual Property Law at Wong Partnership, in Reuters
- “Patents are a central part of how pharma does business. Pharma products require longer and more complex research and development (R&D) cycles than products in other industries. Consequently, companies invest significant amounts of money into their new products early on in their development. Patent protection enables companies to recoup that R&D investment and continue to produce innovative, new drugs in the future.” – Alexandra Nawrat, Senior Medical Journalist at Verdict, in Pharmaceutical-Technology
For more information on the importance of IP rights, visit our IP page and stay tuned for our next IP Explained post.